COVID-19 – News

EOP: COVID-19 and Public Health Preparedness and Response Federal Register

Apr 17, 2024 - Executive Order from the Office of the President revoking three executive orders related to COVID-19 – Executive Order 13910 of March 23, 2020, Executive Order 13991 of January 20, 2021, and Executive Order 13998 of January 21, 2021. This order also transfers the responsibilities of the Coordinator of the COVID-19 Response and Counselor to the President to the Director of the Office of Pandemic Preparedness and Response Policy (OPPR) and terminates the COVID-19 Response Coordinator and Deputy Coordinator of the COVID-19 Response positions.

view details

FDA: Revocation of Six Authorizations of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability Federal Register

Mar 21, 2024 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Life Technologies Corp.; Bio-Rad Laboratories, Inc.; Revvity, Inc.; bioMérieux SA; and Luminex Corp. related to COVID-19 detection and diagnosis tests.

view details

FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability Federal Register

Mar 11, 2024 - Notice from the Food and Drug Administration (FDA) announcing the revocation of one Emergency Use Authorization (EUA) issued to Eli Lilly and Co. (Lilly) for bamlanivimab and etesevimab administered together. The revocation is effective December 14, 2023.

view details